Horizon Therapeutics Public Limited Company Stock Price and Value Analysis

Should you buy Horizon Therapeutics Public Limited Company stock? (NasdaqGS:HZNP). Let's see how it does in our automated value investing analysis system.

  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the HZNP Numbers

HZNP Price
(Horizon Therapeutics Public Limited Company stock price per share)
[?] PE Ratio versus Sector 208% higher than other Healthcare stocks
[?] PE Ratio versus Industry 485% higher than other Unknown stocks
[?] Cash Yield 1.30%
[?] Free Cash Flow Jitter 76%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 8,459,540 shares shorted. With 227,910,045 shares available for purchase and an average trading volume over the past 10 trading days of 9,016,900, it would take at least 0.938 days for all of the short holders to cover their shorts.

Is Horizon Therapeutics Public Limited Company Stock on Sale?

Based on our analysis, we believe that you should not buy Horizon Therapeutics Public Limited Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy HZNP Stock?

Does Horizon Therapeutics Public Limited Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.